ABBV vs RVTY
By Alex · Tickerpine
AbbVie Inc. vs Revvity, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | RVTY |
|---|---|---|
| Price | $295.03 | $154.39 |
| Market cap | $521.50B | $17.24B |
| P/E ratio | 50.7 | 68.6 |
| ROE | — | 3.45% |
| Profit margin | 15.67% | 8.61% |
| Revenue growth | 10.30% | 4.30% |
| Dividend yield | 2.35% | 0.18% |
| Beta | 0.19 | 1.09 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs RVTY in plain English
- ABBV is the bigger company — about 30.3× the market cap of RVTY.
- ABBV is cheaper on earnings (P/E 50.7 vs 68.6).
- ABBV is growing revenue faster (10% vs 4%).
- ABBV has the higher dividend yield (2.35% vs 0.18%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
RVTY return calculator
See what $1,000 in Revvity, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.